The international Advisory Group for the programme consists of leading experts providing expertise in both the research and treatment of prostate cancer and the design and conduct of meta-analyses. The Programme Management Group will draw on their expertise in making important and strategic decisions. Together they will be jointly responsible for the oversight of the programme to ensure planned objectives are achieved. The Programme Management Group and the international Advisory Group will also work closely with key collaborators.
Dana-Faber Cancer Institute, Boston, MA, USA
Université catholique de Louvain, Cliniques universitaires Saint-Luc, Brussels, Belgium
MRC Clinical Trials Unit and the Institute of Clinical Trials and Methodology at University College London, UK